<?xml version="1.0" encoding="utf-8"?><api:response xmlns:api="http://www.symplectic.co.uk/publications/api"><api:version uri="https://mypublications.shef.ac.uk/" elements-version="6.15.0.3976" schema-version="6.13" product-name="myPublications"/><api:request href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/463"/><api:result><api:object category="publication" id="463" last-affected-when="2024-03-17T08:10:49.483+00:00" last-modified-when="2024-03-17T08:10:49.483+00:00" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/463" created-when="2010-05-17T13:46:20.773+01:00" type-id="5" type-display-name="Journal article" type="journal-article"><api:privacy-level>Public</api:privacy-level><api:privacy-level-locked>false</api:privacy-level-locked><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2001-12-25</api:reporting-date-1><api:allow-type-switching>true</api:allow-type-switching><api:records><api:record format="native" id="1518186" source-id="13" source-name="crossref" source-display-name="Crossref" id-at-source="10.1046/j.1365-2559.1999.00703.x" last-modified-when="2023-09-09T07:02:40.883+01:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>&lt;jats:sec&gt;&lt;jats:title&gt;Aims&lt;/jats:title&gt;&lt;jats:p&gt;Although several genetic abnormalities are known to occur in endometrial cancer, including &lt;jats:italic&gt;tp53&lt;/jats:italic&gt; gene mutation, the pathogenesis of this common malignancy remains poorly defined. We investigated the relationship between overexpression of p53 protein, p21 protein expression and apoptosis in endometrial carcinoma.&lt;/jats:p&gt;&lt;/jats:sec&gt;&lt;jats:sec&gt;&lt;jats:title&gt;Methods and results&lt;/jats:title&gt;&lt;jats:p&gt;Sixteen cases of endometrial carcinoma in which polymerase chain reaction analysis had demonstrated the absence of a &lt;jats:italic&gt;tp53&lt;/jats:italic&gt; gene mutation were selected on the basis of p53 protein expression; p21 protein expression and the apoptotic index were then determined for each case. The proportion of cells in each case expressing p53 and p21 protein immunoreactivity was compared with the apoptotic index. Overall, no significant correlation was demonstrated between p53 and p21 immunoreactivity, or between either p53 or p21 and the apoptotic index.&lt;/jats:p&gt;&lt;/jats:sec&gt;&lt;jats:sec&gt;&lt;jats:title&gt;Conclusions&lt;/jats:title&gt;&lt;jats:p&gt;Factors other than p53 are involved in the regulation of p21 expression and apoptosis in endometrioid endometrial adenocarcinomas without &lt;jats:italic&gt;p53&lt;/jats:italic&gt; mutations. Despite the small numbers used in this study, the data suggest a correlation between low levels of p53 immunoreactivity and apoptosis. We postulate that high levels of p53 immunoreactivity may be due to abnormal stabilization of the p53 protein. Follow‚Äêup studies are needed with a larger data set.&lt;/jats:p&gt;&lt;/jats:sec&gt;</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="971" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/971"/></api:links><api:last-name>Burton</api:last-name><api:initials></api:initials></api:person><api:person><api:last-name>Stewart</api:last-name><api:initials></api:initials></api:person><api:person><api:last-name>Heatley</api:last-name><api:initials></api:initials></api:person><api:person><api:last-name>Royds</api:last-name><api:initials></api:initials></api:person><api:person><api:links><api:link type="elements/user" id="886" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/886"/></api:links><api:last-name>Wells</api:last-name><api:initials></api:initials></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1365-2559.1999.00703.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1365-2559.1999.00703.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1365-2559.1999.00703.x"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1365-2559</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973954"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0309-0167</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973954"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Histopathology</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>en</api:text></api:field><api:field name="online-publication-date" type="date" display-name="Online publication date"><api:date><api:day>25</api:day><api:month>12</api:month><api:year>2001</api:year></api:date></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>221</api:begin-page><api:end-page>229</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>9</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Wiley</api:text></api:field><api:field name="publisher-url" type="text" display-name="Link 2"><api:text>http://dx.doi.org/10.1046/j.1365-2559.1999.00703.x</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>29</api:day><api:month>8</api:month><api:year>2023</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>p53 expression, p21 expression and the apoptotic index in endometrioid endometrial adenocarcinoma</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>35</api:text></api:field></api:native></api:record><api:record format="native" id="94555" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-0032861609" last-modified-when="2020-09-01T22:02:16.55+01:00"><api:citation-count>16</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Aims: Although several genetic abnormalities are known to occur in endometrial cancer, including tp53 gene mutation, the pathogenesis of this common malignancy remains poorly defined. We investigated the relationship between overexpression of p53 protein, p21 protein expression and apoptosis in endometrial carcinoma. Methods and results: Sixteen cases of endometrial carcinoma in which polymerase chain reaction analysis had demonstrated the absence of a tp53 gene mutation were selected on the basis of p53 protein expression; p21 protein expression and the apoptotic index were then determined for each case. The proportion of cells in each case expressing p53 and p21 protein immunoreactivity was compared with the apoptotic index. Overall, no significant correlation was demonstrated between p53 and p21 immunoreactivity, or between either p53 or p21 and the apoptotic index. Conclusions: Factors other than p53 are involved in the regulation of p21 expression and apoptosis in endometrioid endometrial adenocarcinomas without p53 mutations. Despite the small numbers used in this study, the data suggest a correlation between low levels of p53 immunoreactivity and apoptosis. We postulate that high levels of p53 immunoreactivity may be due to abnormal stabilization of the p53 protein. Follow-up studies are needed with a larger data set.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="971" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/971"/></api:links><api:last-name>Burton</api:last-name><api:initials>JL</api:initials><api:first-names>JL</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>L</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The Sheffield Medical School</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7403200783</api:identifier></api:identifiers></api:person><api:person><api:last-name>Stewart</api:last-name><api:initials>RL</api:initials><api:first-names>RL</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>L</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The Sheffield Medical School</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">14039465300</api:identifier></api:identifiers></api:person><api:person><api:last-name>Heatley</api:last-name><api:initials>MK</api:initials><api:first-names>MK</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>K</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Royal Liverpool University Hospital</api:line><api:line type="city">Liverpool</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7006654285</api:identifier></api:identifiers></api:person><api:person><api:last-name>Royds</api:last-name><api:initials>JA</api:initials><api:first-names>JA</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The Sheffield Medical School</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7003622251</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="886" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/886"/></api:links><api:last-name>Wells</api:last-name><api:initials>M</api:initials><api:first-names>M</api:first-names><api:separate-first-names><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The Sheffield Medical School</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7402076290</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1365-2559.1999.00703.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1365-2559.1999.00703.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1365-2559.1999.00703.x"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10469214</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0309-0167</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973954"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Histopathology</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>221</api:begin-page><api:end-page>229</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>18</api:day><api:month>10</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>p53 expression, p21 expression and the apoptotic index in endometrioid endometrial adenocarcinoma</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>35</api:text></api:field></api:native></api:record><api:record format="native" id="463" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="10469214" last-modified-when="2020-04-29T04:24:27.673+01:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>AIMS: Although several genetic abnormalities are known to occur in endometrial cancer, including tp53 gene mutation, the pathogenesis of this common malignancy remains poorly defined. We investigated the relationship between overexpression of p53 protein, p21 protein expression and apoptosis in endometrial carcinoma. METHODS AND RESULTS: Sixteen cases of endometrial carcinoma in which polymerase chain reaction analysis had demonstrated the absence of a tp53 gene mutation were selected on the basis of p53 protein expression; p21 protein expression and the apoptotic index were then determined for each case. The proportion of cells in each case expressing p53 and p21 protein immunoreactivity was compared with the apoptotic index. Overall, no significant correlation was demonstrated between p53 and p21 immunoreactivity, or between either p53 or p21 and the apoptotic index. CONCLUSIONS: Factors other than p53 are involved in the regulation of p21 expression and apoptosis in endometrioid endometrial adenocarcinomas without p53 mutations. Despite the small numbers used in this study, the data suggest a correlation between low levels of p53 immunoreactivity and apoptosis. We postulate that high levels of p53 immunoreactivity may be due to abnormal stabilization of the p53 protein. Follow-up studies are needed with a larger data set.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="971" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/971"/></api:links><api:last-name>Burton</api:last-name><api:initials>JL</api:initials><api:first-names>JL</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>L</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">Department of Pathology, University of Sheffield Medical School, UK.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Stewart</api:last-name><api:initials>RL</api:initials><api:first-names>RL</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>L</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Heatley</api:last-name><api:initials>MK</api:initials><api:first-names>MK</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>K</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Royds</api:last-name><api:initials>JA</api:initials><api:first-names>JA</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="886" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/886"/></api:links><api:last-name>Wells</api:last-name><api:initials>M</api:initials><api:first-names>M</api:first-names><api:separate-first-names><api:first-name>M</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.ncbi.nlm.nih.gov/pubmed/10469214</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1365-2559.1999.00703.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1365-2559.1999.00703.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1365-2559.1999.00703.x"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0309-0167</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973954"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Histopathology</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Aged</api:keyword><api:keyword scheme="mesh">Aged, 80 and over</api:keyword><api:keyword scheme="mesh">Apoptosis</api:keyword><api:keyword scheme="mesh">Carcinoma, Endometrioid</api:keyword><api:keyword scheme="mesh">Cyclin-Dependent Kinase Inhibitor p21</api:keyword><api:keyword scheme="mesh">Cyclins</api:keyword><api:keyword scheme="mesh">Endometrial Neoplasms</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Immunohistochemistry</api:keyword><api:keyword scheme="mesh">Linear Models</api:keyword><api:keyword scheme="mesh">Middle Aged</api:keyword><api:keyword scheme="mesh">Statistics, Nonparametric</api:keyword><api:keyword scheme="mesh">Tumor Suppressor Protein p53</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>England</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>221</api:begin-page><api:end-page>229</api:end-page></api:pagination></api:field><api:field name="pii" type="text" display-name="PII"><api:text>his703</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>9</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>26</api:day><api:month>10</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>p53 expression, p21 expression and the apoptotic index in endometrioid endometrial adenocarcinoma.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>35</api:text></api:field></api:native></api:record><api:record format="native" id="881850" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:10469214" last-modified-when="2024-02-13T19:34:19.81+00:00"><api:citation-count>10</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>&lt;h4&gt;Aims&lt;/h4&gt;Although several genetic abnormalities are known to occur in endometrial cancer, including tp53 gene mutation, the pathogenesis of this common malignancy remains poorly defined. We investigated the relationship between overexpression of p53 protein, p21 protein expression and apoptosis in endometrial carcinoma.&lt;h4&gt;Methods and results&lt;/h4&gt;Sixteen cases of endometrial carcinoma in which polymerase chain reaction analysis had demonstrated the absence of a tp53 gene mutation were selected on the basis of p53 protein expression; p21 protein expression and the apoptotic index were then determined for each case. The proportion of cells in each case expressing p53 and p21 protein immunoreactivity was compared with the apoptotic index. Overall, no significant correlation was demonstrated between p53 and p21 immunoreactivity, or between either p53 or p21 and the apoptotic index.&lt;h4&gt;Conclusions&lt;/h4&gt;Factors other than p53 are involved in the regulation of p21 expression and apoptosis in endometrioid endometrial adenocarcinomas without p53 mutations. Despite the small numbers used in this study, the data suggest a correlation between low levels of p53 immunoreactivity and apoptosis. We postulate that high levels of p53 immunoreactivity may be due to abnormal stabilization of the p53 protein. Follow-up studies are needed with a larger data set.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">Department of Pathology, University of Sheffield Medical School, UK.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="971" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/971"/></api:links><api:last-name>Burton</api:last-name><api:initials>JL</api:initials><api:first-names>JL</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>L</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Stewart</api:last-name><api:initials>RL</api:initials><api:first-names>RL</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>L</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Heatley</api:last-name><api:initials>MK</api:initials><api:first-names>MK</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>K</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Royds</api:last-name><api:initials>JA</api:initials><api:first-names>JA</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="886" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/886"/></api:links><api:last-name>Wells</api:last-name><api:initials>M</api:initials><api:first-names>M</api:first-names><api:separate-first-names><api:first-name>M</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1365-2559.1999.00703.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1365-2559.1999.00703.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1365-2559.1999.00703.x"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1365-2559</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973954"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10469214</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>false</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0309-0167</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973954"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Histopathology</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Carcinoma, Endometrioid</api:keyword><api:keyword scheme="mesh">Endometrial Neoplasms</api:keyword><api:keyword scheme="mesh">Cyclins</api:keyword><api:keyword scheme="mesh">Immunohistochemistry</api:keyword><api:keyword scheme="mesh">Linear Models</api:keyword><api:keyword scheme="mesh">Statistics, Nonparametric</api:keyword><api:keyword scheme="mesh">Apoptosis</api:keyword><api:keyword scheme="mesh">Aged</api:keyword><api:keyword scheme="mesh">Aged, 80 and over</api:keyword><api:keyword scheme="mesh">Middle Aged</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Tumor Suppressor Protein p53</api:keyword><api:keyword scheme="mesh">Cyclin-Dependent Kinase Inhibitor p21</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>221</api:begin-page><api:end-page>229</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>9</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>1</api:day><api:month>9</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>p53 expression, p21 expression and the apoptotic index in endometrioid endometrial adenocarcinoma.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Research Support, Non-U.S. Gov't</api:item><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>35</api:text></api:field></api:native></api:record><api:record format="native" id="2908929" source-id="10" source-name="dimensions" source-display-name="Dimensions" id-at-source="pub.1043675166" last-modified-when="2024-03-17T08:10:49.49+00:00"><api:citation-count>12</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="971" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/971"/></api:links><api:last-name>Burton</api:last-name><api:initials></api:initials><api:addresses><api:address><api:line type="full">Department of Pathology</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0700076574.07</api:identifier></api:identifiers></api:person><api:person><api:last-name>Stewart</api:last-name><api:initials></api:initials><api:addresses><api:address><api:line type="full">Department of Pathology</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01157265524.94</api:identifier></api:identifiers></api:person><api:person><api:last-name>Heatley</api:last-name><api:initials></api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Royal Liverpool University Hospital</api:line><api:line type="city">Liverpool</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01126307744.52</api:identifier></api:identifiers></api:person><api:person><api:last-name>Royds</api:last-name><api:initials></api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses></api:person><api:person><api:links><api:link type="elements/user" id="886" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/886"/></api:links><api:last-name>Wells</api:last-name><api:initials></api:initials><api:addresses><api:address><api:line type="full">Department of Pathology</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01173472640.07</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1365-2559.1999.00703.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1365-2559.1999.00703.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1365-2559.1999.00703.x"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10469214</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0309-0167</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973954"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Histopathology</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="for-2020">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020">3211 Oncology and Carcinogenesis</api:keyword><api:keyword scheme="rcdc">Cancer</api:keyword><api:keyword scheme="rcdc">Genetics</api:keyword><api:keyword scheme="rcdc">Uterine Cancer</api:keyword><api:keyword scheme="hrcs-rac">2.1 Biological and endogenous factors</api:keyword><api:keyword scheme="hrcs-rac">2 Aetiology</api:keyword><api:keyword scheme="mesh">Aged</api:keyword><api:keyword scheme="mesh">Aged, 80 and over</api:keyword><api:keyword scheme="mesh">Apoptosis</api:keyword><api:keyword scheme="mesh">Carcinoma, Endometrioid</api:keyword><api:keyword scheme="mesh">Cyclin-Dependent Kinase Inhibitor p21</api:keyword><api:keyword scheme="mesh">Cyclins</api:keyword><api:keyword scheme="mesh">Endometrial Neoplasms</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Immunohistochemistry</api:keyword><api:keyword scheme="mesh">Linear Models</api:keyword><api:keyword scheme="mesh">Middle Aged</api:keyword><api:keyword scheme="mesh">Statistics, Nonparametric</api:keyword><api:keyword scheme="mesh">Tumor Suppressor Protein p53</api:keyword></api:keywords></api:field><api:field name="online-publication-date" type="date" display-name="Online publication date"><api:date><api:day>25</api:day><api:month>12</api:month><api:year>2001</api:year></api:date></api:field><api:field name="open-access-status" type="text" display-name="Open access status"><api:text>Closed Access</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>221</api:begin-page><api:end-page>229</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>9</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Wiley</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>31</api:day><api:month>8</api:month><api:year>2017</api:year></api:date></api:field><api:field name="relative-citation-ratio" type="decimal" display-name="Relative citation ratio"><api:decimal>0.42</api:decimal></api:field><api:field name="title" type="text" display-name="Title"><api:text>p53 expression, p21 expression and the apoptotic index in endometrioid endometrial adenocarcinoma</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>35</api:text></api:field></api:native></api:record><api:record format="native" id="240671" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000082837400005" last-modified-when="2024-03-14T05:53:25.753+00:00"><api:citation-count>16</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="971" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/971"/></api:links><api:last-name>Burton</api:last-name><api:initials>JL</api:initials><api:first-names>JL</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>L</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Stewart</api:last-name><api:initials>RL</api:initials><api:first-names>RL</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>L</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Heatley</api:last-name><api:initials>MK</api:initials><api:first-names>MK</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>K</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Royds</api:last-name><api:initials>JA</api:initials><api:first-names>JA</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="886" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/886"/></api:links><api:last-name>Wells</api:last-name><api:initials>M</api:initials><api:first-names>M</api:first-names><api:separate-first-names><api:first-name>M</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.webofscience.com/api/gateway?GWVersion=2&amp;SrcApp=sheffield_elements_live&amp;SrcAuth=WosAPI&amp;KeyUT=WOS:000082837400005&amp;DestLinkType=FullRecord&amp;DestApp=WOS_CPL</api:text></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">240QV</api:identifier><api:identifier scheme="pubmed">10469214</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0309-0167</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973954"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>HISTOPATHOLOGY</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>apoptosis</api:keyword><api:keyword>endometrial cancer</api:keyword><api:keyword>immunohistochemistry</api:keyword><api:keyword>p53</api:keyword><api:keyword>p21</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>221</api:begin-page><api:end-page>229</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>p53 expression, p21 expression and the apoptotic index in endometrioid endometrial adenocarcinoma</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>35</api:text></api:field></api:native></api:record><api:record format="native" id="23428" source-id="3" source-name="wos" source-display-name="Web of Science" id-at-source="WOS:000082837400005" last-modified-when="2014-07-25T11:03:27.62+01:00"><api:citation-count>15</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="971" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/971"/></api:links><api:last-name>Burton</api:last-name><api:initials>JL</api:initials><api:first-names>JL</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>L</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Stewart</api:last-name><api:initials>RL</api:initials><api:first-names>RL</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>L</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Heatley</api:last-name><api:initials>MK</api:initials><api:first-names>MK</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>K</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Royds</api:last-name><api:initials>JA</api:initials><api:first-names>JA</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="886" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/886"/></api:links><api:last-name>Wells</api:last-name><api:initials>M</api:initials><api:first-names>M</api:first-names><api:separate-first-names><api:first-name>M</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0309-0167</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973954"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>HISTOPATHOLOGY</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>apoptosis</api:keyword><api:keyword>endometrial cancer</api:keyword><api:keyword>immunohistochemistry</api:keyword><api:keyword>p53</api:keyword><api:keyword>p21</api:keyword><api:keyword>IMMUNOHISTOCHEMICAL ANALYSIS</api:keyword><api:keyword>PROLIFERATIVE ACTIVITY</api:keyword><api:keyword>CARCINOMA</api:keyword><api:keyword>OVEREXPRESSION</api:keyword><api:keyword>PROTEIN</api:keyword><api:keyword>CANCER</api:keyword><api:keyword>NEOPLASMS</api:keyword><api:keyword>PRODUCT</api:keyword><api:keyword>TUMORS</api:keyword><api:keyword>BCL-2</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>221</api:begin-page><api:end-page>229</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>9</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>p53 expression, p21 expression and the apoptotic index in endometrioid endometrial adenocarcinoma</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>35</api:text></api:field></api:native></api:record></api:records><api:fields/><api:all-labels type="keyword-list"><api:keywords><api:keyword scheme="mesh" origin="record-data" source="pubmed">Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Aged, 80 and over</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Apoptosis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Carcinoma, Endometrioid</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Cyclin-Dependent Kinase Inhibitor p21</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Cyclins</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Endometrial Neoplasms</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Immunohistochemistry</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Linear Models</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Middle Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Statistics, Nonparametric</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Tumor Suppressor Protein p53</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Carcinoma, Endometrioid</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Endometrial Neoplasms</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Cyclins</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Immunohistochemistry</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Linear Models</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Statistics, Nonparametric</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Apoptosis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Aged, 80 and over</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Middle Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Tumor Suppressor Protein p53</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Cyclin-Dependent Kinase Inhibitor p21</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">3211 Oncology and Carcinogenesis</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Cancer</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Genetics</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Uterine Cancer</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">2.1 Biological and endogenous factors</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">2 Aetiology</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Aged, 80 and over</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Apoptosis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Carcinoma, Endometrioid</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Cyclin-Dependent Kinase Inhibitor p21</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Cyclins</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Endometrial Neoplasms</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Immunohistochemistry</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Linear Models</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Middle Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Statistics, Nonparametric</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Tumor Suppressor Protein p53</api:keyword><api:keyword origin="record-data" source="wos-lite">apoptosis</api:keyword><api:keyword origin="record-data" source="wos-lite">endometrial cancer</api:keyword><api:keyword origin="record-data" source="wos-lite">immunohistochemistry</api:keyword><api:keyword origin="record-data" source="wos-lite">p53</api:keyword><api:keyword origin="record-data" source="wos-lite">p21</api:keyword><api:keyword origin="record-data" source="wos">apoptosis</api:keyword><api:keyword origin="record-data" source="wos">endometrial cancer</api:keyword><api:keyword origin="record-data" source="wos">immunohistochemistry</api:keyword><api:keyword origin="record-data" source="wos">p53</api:keyword><api:keyword origin="record-data" source="wos">p21</api:keyword><api:keyword origin="record-data" source="wos">IMMUNOHISTOCHEMICAL ANALYSIS</api:keyword><api:keyword origin="record-data" source="wos">PROLIFERATIVE ACTIVITY</api:keyword><api:keyword origin="record-data" source="wos">CARCINOMA</api:keyword><api:keyword origin="record-data" source="wos">OVEREXPRESSION</api:keyword><api:keyword origin="record-data" source="wos">PROTEIN</api:keyword><api:keyword origin="record-data" source="wos">CANCER</api:keyword><api:keyword origin="record-data" source="wos">NEOPLASMS</api:keyword><api:keyword origin="record-data" source="wos">PRODUCT</api:keyword><api:keyword origin="record-data" source="wos">TUMORS</api:keyword><api:keyword origin="record-data" source="wos">BCL-2</api:keyword><api:keyword scheme="for" origin="issn-inferred">1103 Clinical Sciences</api:keyword><api:keyword scheme="science-metrix" origin="issn-inferred">Pathology</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3202 Clinical sciences</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3211 Oncology and carcinogenesis</api:keyword></api:keywords></api:all-labels><api:journal issn="0309-0167" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973954" title="Histopathology"><api:records><api:record source-name="summary"><api:title>Histopathology</api:title></api:record></api:records></api:journal><api:relationships href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/463/relationships"/></api:object></api:result></api:response>